By Maureen Lafrenière Last year’s federal budget commitment of $300 million to vaccinate girls and women against human papillomavirus (HPV) received a mixed reaction from consumers, health professionals and the media. Although preceded by Health Canada approval in 2006 and a positive recommendation from the National Advisory Committee on Immunization, the March 2007 budget announcement took […]